119 related articles for article (PubMed ID: 29150704)
1. Evaluation of immune-mediated idiosyncratic drug toxicity using chimeric HLA transgenic mice.
Susukida T; Aoki S; Kogo K; Fujimori S; Song B; Liu C; Sekine S; Ito K
Arch Toxicol; 2018 Mar; 92(3):1177-1188. PubMed ID: 29150704
[TBL] [Abstract][Full Text] [Related]
2. An Animal Model of Abacavir-Induced HLA-Mediated Liver Injury.
Song B; Aoki S; Liu C; Susukida T; Ito K
Toxicol Sci; 2018 Apr; 162(2):713-723. PubMed ID: 29319822
[TBL] [Abstract][Full Text] [Related]
3. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.
Susukida T; Kuwahara S; Song B; Kazaoka A; Aoki S; Ito K
Commun Biol; 2021 Sep; 4(1):1137. PubMed ID: 34584206
[TBL] [Abstract][Full Text] [Related]
5. [Importance of HLA in Determining Individual Differences in the Onset of Adverse Drug Reactions].
Aoki S
Yakugaku Zasshi; 2021; 141(8):1001-1007. PubMed ID: 34334545
[TBL] [Abstract][Full Text] [Related]
6. HLA transgenic mice: application in reproducing idiosyncratic drug toxicity.
Susukida T; Aoki S; Shirayanagi T; Yamada Y; Kuwahara S; Ito K
Drug Metab Rev; 2020 Nov; 52(4):540-567. PubMed ID: 32847422
[TBL] [Abstract][Full Text] [Related]
7. The PD1 inhibitory pathway and mature dendritic cells contribute to abacavir hypersensitivity in human leukocyte antigen transgenic PD1 knockout mice.
Song B; Aoki S; Liu C; Susukida T; Kuwahara S; Ito K
Toxicology; 2021 Nov; 463():152971. PubMed ID: 34606953
[TBL] [Abstract][Full Text] [Related]
8. TARC/CCL17 Expression Is Associated with CD8
Gao Y; Kuwahara S; Kazaoka A; Ito K; Aoki S
Biol Pharm Bull; 2022; 45(9):1347-1353. PubMed ID: 36047204
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of human serum albumin and flucloxacillin provokes specific immune response in HLA-B*57:01 transgenic mice.
Gao Y; Song B; Aoki S; Ito K
Immunol Lett; 2022 Sep; 249():5-11. PubMed ID: 35963284
[TBL] [Abstract][Full Text] [Related]
10. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
[TBL] [Abstract][Full Text] [Related]
11. New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals.
Pavlos R; Deshpande P; Chopra A; Leary S; Strautins K; Nolan D; Thorborn D; Shaefer M; Rauch A; Dunn D; Montaner J; Rachlis A; Almeida CA; Choo L; James I; Redwood AJ; Li Y; Gaudieri S; Mallal SA; Phillips EJ
Hum Immunol; 2020 Jun; 81(6):300-304. PubMed ID: 32173028
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity.
Chessman D; Kostenko L; Lethborg T; Purcell AW; Williamson NA; Chen Z; Kjer-Nielsen L; Mifsud NA; Tait BD; Holdsworth R; Almeida CA; Nolan D; Macdonald WA; Archbold JK; Kellerher AD; Marriott D; Mallal S; Bharadwaj M; Rossjohn J; McCluskey J
Immunity; 2008 Jun; 28(6):822-32. PubMed ID: 18549801
[TBL] [Abstract][Full Text] [Related]
13. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
14. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire.
Illing PT; Vivian JP; Dudek NL; Kostenko L; Chen Z; Bharadwaj M; Miles JJ; Kjer-Nielsen L; Gras S; Williamson NA; Burrows SR; Purcell AW; Rossjohn J; McCluskey J
Nature; 2012 Jun; 486(7404):554-8. PubMed ID: 22722860
[TBL] [Abstract][Full Text] [Related]
15. Avidity determines T-cell reactivity in abacavir hypersensitivity.
Adam J; Eriksson KK; Schnyder B; Fontana S; Pichler WJ; Yerly D
Eur J Immunol; 2012 Jul; 42(7):1706-16. PubMed ID: 22585534
[TBL] [Abstract][Full Text] [Related]
16. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
17. Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules.
Puig M; Norcross MA
Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):279-286. PubMed ID: 37284777
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the Mechanisms Underlying Interindividual Differences in the Onset of Adverse Drug Reactions.
Aoki S
Biol Pharm Bull; 2024; 47(6):1079-1086. PubMed ID: 38825461
[TBL] [Abstract][Full Text] [Related]
19. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
20. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
Gerberick GF; Cruse LW; Ryan CA
Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
